Medical sector investments in Oman's Raysut Industrial City surpass $143mln
The city is currently finalising contracts for three new projects focused on the production of eye drops, blood bags, and a range of medical supplies. Additionally, a veterinary related facility is currently under development in Raysut Industrial City.
Raysut Industrial City is currently home to three operating projects in the medical sector with a total investment volume surpassing RO 55 million. Occupying a combined area exceeding 72,000 square metres, the operating projects are specialised in producing antibiotics, hormones, topical preparations, effervescent tablets, solid and liquid oral dosage forms, intravenous solutions, dialysis fluids, medical gloves, masks, cotton products, bandages, adhesive tapes, and more.
By attracting and localising investments in the medical sector, Madayn aims at enhancing the Sultanate of Oman's pharmaceutical security, encourage local and foreign investments in the sector, reduce reliance on imported pharmaceuticals, and boost local production capacity. These efforts align with Oman Vision 2040 objectives to advance industrial development and achieve self-sufficiency in key sectors.
2022 © All right reserved for Oman Establishment for Press, Publication and Advertising (OEPPA) Provided by SyndiGate Media Inc. (Syndigate.info).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
20 hours ago
- Zawya
Pharma drags London stocks lower after Trump's tariff blitz
British equities slipped on Friday, pressured by healthcare shares, as investors woke up to U.S. President Donald Trump's fresh levies on dozens of countries and demands to lower prescription drug prices. The blue-chip FTSE 100 was down 0.7% as of 0915 GMT, on track to snap a six-week winning streak. The domestically focused midcap FTSE 250 fell nearly 1% and headed for its second straight weekly decline. Late on Thursday, Trump slapped steep tariffs on exports from dozens of trading partners including Canada, Brazil, India, Taiwan and Switzerland, pressing ahead with his plans to reorder the global economy. British healthcare stocks dropped the most, down 2.3%, after Trump sent letters to the leaders of 17 major pharmaceutical companies on Thursday, including AstraZeneca and GSK, outlining how they should slash U.S. prescription drug prices. AstraZeneca shed 3.4%, while GSK slipped 1.3%. Industrial Support Services sector fell 2.1% after Intertek Group missed its half-year organic revenue growth. The British product testing firm fell the most in the FTSE 100, down 7.7%. British Airways owner IAG dropped 2.1% after the airline group said it expected a slight rise in costs linked to air traffic control issues. Watches of Switzerland was the biggest drag on the FTSE 250, down 8%, after the U.S. imposed a 39% tariff on Swiss imports. Conversely, Melrose Industries rose 6.5% to the top of the benchmark index, after the defence company beat operating profit expectations on strong demand. Pearson rose 4.5% after the British education company forecast stronger growth in the second half. Meanwhile, Britain said the European Union will remove tariffs on key steel products under a quota system from Friday as part of a reset of ties and a recent deal to ease trade barriers. However, London is yet to conclude negotiations with the U.S. after both sides agreed in May to work toward removing tariffs on British steel exports. Also, data showed on Friday that British house prices rose slightly faster than expected in July. (Reporting by Sanchayaita Roy in Bengaluru; Editing by Sahal Muhammed)
Zawya
a day ago
- Zawya
European shares slide to 4-week lows as US slaps tariffs on dozens of countries
European stocks hit a 4-week low on Friday at the end of a busy week as investors worried about the impact of fresh U.S. levies on dozens of countries, including a 39% tariff on Switzerland. Trump continued his tariff blitz, announcing steep levies on exports from dozens of trading partners including Canada, Brazil, India and Taiwan with countries not listed subject to a base 10% rate ahead of a Friday trade deal deadline. Healthcare stocks dropped 1.6% after U.S. President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies, including Novo Nordisk and Sanofi, outlining how they should slash U.S. prescription drug prices. Denmark-listed Novo Nordisk shed 4.9%, falling to an almost four-year low. Shares of the Wegovy-maker are also set for the steepest-ever weekly fall. "Trump is trying to force these foreign companies to reduce the cost of drugs and medicines exported to the U.S. in order to balance the cuts in subsidies with the big beautiful bill," said Mabrouk Chetouane, head of Global Market Strategy at Nataxis Investment Managers. "I think the pressure will be extremely strong on the healthcare sector because the U.S. is clearly one of the markets where margins are quite significant." The pan-European STOXX 600 index fell 1.3% by 0915 GMT, down for the third straight session and on track to end the week in the red. The benchmark index has slipped 4.4% from its March peak, after coming within 2% of that level earlier this week, dragged down by a record plunge in Novo Nordisk shares following a profit warning, and as investors assess the implications of the U.S.-EU trade deal. Germany's blue-chip DAX shed 1.7%, while Denmark's OMXC fell 3% to a nearly two-year low. Most regional bourses were in the red. Stock markets in Switzerland were shut for a holiday. Among individual stocks, Italy's Campari was the top gainer on the STOXX 600 index, adding 6.7% after reporting an increase in second-quarter operating profit. UK's Melrose Industries' shares rose 6.4% and ranked among the top gainers after the defense company beat analysts' operating profit expectations on strong demand. British Airways owner IAG shares dropped 1.8% after rising in early trade on quarterly earnings, after the airline group said it expected a slight rise in costs linked to air traffic control issues. A latest survey showed euro zone manufacturing moved closer to stabilization in July, giving further credence to European Central Bank's modestly upbeat assessment of the economy last week. Eyes will be on U.S. payrolls data slated for later in the day after euro zone inflation held steady at ECB's 2% target in July. Investors have pared bets on ECB rate cuts, placing only a 44% chance of another quarter-point move by December. (Reporting by Twesha Dikshit and Medha Singh; Editing by Mrigank Dhaniwala and Shinjini Ganguli)
Zawya
a day ago
- Zawya
Oman: FSA denies minimum price hike for vehicle insurance
Muscat – The Financial Services Authority (FSA) has responded to recent concerns circulating on social media regarding alleged increases in the minimum prices of vehicle insurance by some insurance companies. In an official statement, the FSA clarified that no approval has been granted to raise the minimum pricing levels for vehicle insurance. The authority emphasized its ongoing role in monitoring insurance pricing to maintain price stability within safe and appropriate limits. The FSA reaffirmed its adherence to the principle of a free market, noting that insurance pricing is determined by several factors, including supply and demand dynamics, the performance of insurance portfolios, and profitability levels. It stated that any change in insurance tariffs must be communicated to the Authority with valid justifications before implementation. The Authority urged policyholders and the public to rely on its official social media channels for accurate and updated information on the insurance market. As the regulatory and supervisory body for Oman's financial non-banking sector, the FSA continues to monitor market practices to ensure fairness and transparency. © Apex Press and Publishing Provided by SyndiGate Media Inc. (
